Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-01 Other | 2024-11-05 6:35 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | Tompkins Mark N. Former Director Director | 3,550,000 | $0 | 4,750,000 (Direct) | View | |
| 2024-11-01 Other | 2024-11-05 6:33 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | Jacobs Ian Seth Former Director and officer Director | 75,000 | $0 | 250,000 (Direct) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 539,062 | $3.2 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 694,444 | $3.6 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Option Award | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 1,443,750 | $4 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:02 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Capital GP VIII LLC OrbiMed Capital GP IX LLC Director | 1,233,506 | $0 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:01 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | GORDON CARL L Director | 539,062 | $3.2 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:01 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | GORDON CARL L Director | 694,444 | $3.6 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Option Award | 2024-11-05 6:01 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | GORDON CARL L Director | 1,443,750 | $4 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:01 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | GORDON CARL L Director | 1,233,506 | $0 | 2,677,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:00 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | Savchuk Nikolay President and COO | 539,062 | $3.2 | 3,935,256 (Indirect) | View | |
| 2024-11-01 Option Award | 2024-11-05 6:00 pm | N/A 2034-09-18 | Lomond Therapeutics Holdings Inc. | Savchuk Nikolay President and COO | 1,258,000 | $0 | 3,935,256 (Direct) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:00 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | Savchuk Nikolay President and COO | 694,444 | $3.6 | 3,935,256 (Indirect) | View | |
| 2024-11-01 Option Award | 2024-11-05 6:00 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | Savchuk Nikolay President and COO | 1,443,750 | $4 | 3,935,256 (Indirect) | View | |
| 2024-11-01 Conversion | 2024-11-05 6:00 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | Savchuk Nikolay President and COO | 1,233,506 | $0 | 3,935,256 (Indirect) | View | |
| 2024-11-01 Option Award | 2024-11-05 6:00 pm | N/A 2034-09-18 | Lomond Therapeutics Holdings Inc. | Dukes Iain D. CEO and Chairman | 2,096,667 | $0 | 2,096,667 (Direct) | View | |
Ownership | 2024-11-05 5:57 pm | N/A N/A | Lomond Therapeutics Holdings Inc. | Eilean Therapeutics LLC 10% Owner | 0 | $0 | 14,420,383 (Direct) | View | |
Ownership | 2022-02-10 9:30 pm | N/A N/A | Venetian-1 Acquisition Corp. | Tompkins Mark N. Director 10% Owner | 0 | $0 | 4,750,000 (Direct) | View | |
Ownership | 2022-02-10 9:30 pm | N/A N/A | Venetian-1 Acquisition Corp. | Jacobs Ian Seth President, CEO, CFO, Secretary 10% Owner | 0 | $0 | 250,000 (Direct) | View |